Ramzi Ajjan

Prof Ajjan’s work collectively aims to reduce cardiovascular complications in diabetes by improving glycaemia and ameliorating the thrombotic environment. His clinical studies have focussed on optimising glycaemic control by reducing high glucose levels, while avoiding hypoglycaemia and keeping glucose variability to a minimum. His translational work aims to uncover novel therapeutic targets to reduce the hypofibrinolytic environment in diabetes, a key abnormality in this condition. He has over 170 publications including original articles, reviews and book chapters. His clinical practice concentrates on young adults with diabetes as well as older individuals at high risk of vascular disease. He is local R&D lead for Diabetes/Endocrinology, regional clinical research network co-lead for diabetes, endocrine and metabolic conditions, and deputy Chair of Clinical Study Group 2 at Diabetes UK. He is an Associate Editor of Diabetes and Vascular Disease Research, and member of the editori